Results 171 to 180 of about 2,021,965 (393)
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Molecular Oncology, EarlyView.Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Molecular Oncology, EarlyView.A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
NEW DIAGNOSTIC POSSIBILITIES AND TRADITIONAL POSITIONS IN MODERN ONCOLOGY
Медицина в Кузбассе, 2021 The article presents the results of our own research on the detection of circulating tumor cells in venous blood in 211 cancer patients and 173 donors from the control group.
Анатолий Агванович Чимитов +4 more
doaj
Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry [PDF]
, 2005 Alison L. Allan +5 more
openalex +1 more source
Molecular Oncology, EarlyView.This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
New England Journal of Medicine, 2004 M. Cristofanilli +10 more
semanticscholar +1 more source
Molecular Oncology, EarlyView.We evaluated circulating tumor DNA (ctDNA) detection in advanced pancreatic cancer using DNA methylation, cell‐free DNA fragment lengths, and 5′ end motifs. Machine learning models were trained to estimate ctDNA levels from each feature and their combination.
Morten Lapin +10 more
wiley +1 more source
Liquid biopsy: from discovery to clinical implementation
Molecular Oncology, 2021 Catherine Alix‐Panabières +1 more
doaj +1 more source
The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis [PDF]
, 2006 Simone Mocellin +4 more
openalex +1 more source